R
Recor Medical, headquartered in Palo Alto, Calif., a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., is a medical technology company focused on transforming the management of hypertension. Recor has pioneered the use of the Paradise Ultrasound Renal Denervation system for the treatment of hypertension. The Paradise system is FDA approved in the United States, bears the CE mark, and is an investigational device in Japan,
Investor insights
Funding rounds participated in
$10M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Medical Equipment Manufacturing
Sectors
Medical Equipment Manufacturing
Funding rounds raised
Total raised
$10M
from investors over 1 rounds
R
Recor Medical raised $10M on July 10, 2016